World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
53021
World Ranking
5481
National Ranking
2952

Overview

Robert J. Fontana is affiliated with the University of Michigan-Ann Arbor in the United States. Their research primarily focuses on medicine and pharmacology, toxicology, and pharmaceutics. Within these fields, they have contributed significantly to specialized subfields including pharmacology, hepatology, epidemiology, oncology, and surgery.

Their work covers several main topics related to liver health and drug safety, such as:

  • Drug-Induced Hepatotoxicity and Protection
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Hepatitis C Virus Research
  • Pharmacogenetics and Drug Metabolism
  • Poisoning and Overdose Treatments
  • Drug Transport and Resistance Mechanisms

Robert J. Fontana has published research in various venues, with a notable number of publications appearing in:

  • UNC Libraries
  • Hepatology
  • The American Journal of Gastroenterology
  • Journal of Hepatology
  • Liver Transplantation

The scientist often collaborates with several frequent co-authors, including:

  • David E. Kleiner
  • Huiman X. Barnhart
  • William M. Lee
  • Paul H. Hayashi
  • Herbert L. Bonkovsky

Among their recent publications are:

  • AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury, 2022, Hepatology
  • A human liver organoid screening platform for DILI risk prediction, 2023, Journal of Hepatology
  • Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement, 2020, Hepatology
  • American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease, 2021, Hepatology
  • United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts, 2020, Toxicology Reports

Best Publications

  • A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C

    Chun-Tao Wai;Joel K. Greenson;Robert J. Fontana;John D. Kalbfleisch

  • Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

    George Ostapowicz;Robert J. Fontana;Frank V. Schioødt;Anne Larson

  • Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study.

    Anne M. Larson;Julie Polson;Robert J. Fontana;Timothy J. Davern

  • Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

    Naga Chalasani;Robert J. Fontana;Herbert L. Bonkovsky;Herbert L. Bonkovsky;Herbert L. Bonkovsky;Paul B. Watkins

  • ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

    Naga P. Chalasani;Paul Hideyo Hayashi;Herbert L. Bonkovsky;Victor J. Navarro

  • Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study

    Naga Chalasani;Herbert L. Bonkovsky;Robert Fontana;William Lee

  • Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis

    M. P. Curry;J. G. O'Leary;N. Bzowej;A. J. Muir

  • Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

    Michael Charlton;Gregory T. Everson;Steven L. Flamm;Princy Kumar

  • Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.

    Kenneth S. Lown;David G. Bailey;Robert J. Fontana;Srinivas K. Janardan

  • Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

    Raymond T. Chung;Marc G. Ghany;Arthur Y. Kim;Kristen M. Marks

  • NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States

    Jorge A. Marrero;Robert J. Fontana;Grace L. Su;Hari S. Conjeevaram

  • Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort

    Jorge A. Marrero;Robert J. Fontana;Ashley Barrat;Frederick Askari

  • Intravenous N-Acetylcysteine Improves Transplant-Free Survival in Early Stage Non-Acetaminophen Acute Liver Failure

    William M. Lee;Linda S. Hynan;Lorenzo Rossaro;Robert J. Fontana

  • Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma

    Jorge A. Marrero;Robert J. Fontana;Sherry Fu;Hari S. Conjeevaram

  • Drug-Induced Liver Injury Network (DILIN) Prospective Study: Rationale, Design and Conduct

    Robert J. Fontana;Paul B. Watkins;Herbert L. Bonkovsky;Naga Chalasani

  • Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence

    Fred Poordad;Eugene R. Schiff;John M. Vierling;Charles Landis

  • Intensive care of patients with acute liver failure: Recommendations of the U.S. Acute Liver Failure Study Group

    R. Todd Stravitz;Andreas H. Kramer;Timothy Davern;A. Obaid S Shaikh

  • Virologic response and resistance to adefovir in patients with chronic hepatitis B

    Scott K. Fung;Hee Bok Chae;Robert J. Fontana;Hari Conjeevaram

  • Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation

    Michael Charlton;Edward Gane;Michael P. Manns;Robert S. Brown

  • Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study

    N. Chalasani;H. L. Bonkovsky;R. Fontana;W. Lee

Frequent Co-Authors

William M. Lee
William M. Lee The University of Texas Southwestern Medical Center
Naga Chalasani
Naga Chalasani Indiana University
Paul B. Watkins
Paul B. Watkins University of North Carolina at Chapel Hill
David E. Kleiner
David E. Kleiner National Institutes of Health
Raymond T. Chung
Raymond T. Chung Harvard University
Anna S.F. Lok
Anna S.F. Lok University of Michigan–Ann Arbor
Robert S. Brown
Robert S. Brown Cornell University
Jay H. Hoofnagle
Jay H. Hoofnagle National Institutes of Health
Herbert L. Bonkovsky
Herbert L. Bonkovsky Wake Forest University
Andres T. Blei
Andres T. Blei Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, there are many online degree programs and career pathways to explore within healthcare. Flexibility, program duration, and accreditation are key factors to evaluate when choosing the right route for your professional goals.

Accreditation is essential for ensuring quality education and employer recognition. For those pursuing healthcare management, it’s important to know which online healthcare degree programs are recognized for their accreditation by cahme? This assurance can help graduates stand out in the competitive job market.

Nursing professionals looking to advance their careers have options for streamlined education. Many RNs can benefit from the best online rn to bsn programs without clinical requirements, making it more convenient to earn a BSN while balancing work and personal commitments.

If your goal is an advanced nursing degree, you may want to research the shortest dnp programs or seek out the easiest online dnp programs for a quicker path to a terminal nursing degree. These options help aspiring leaders and practitioners accelerate their qualifications in a manageable way.

Best Scientists Citing Robert J. Fontana

Trending Scientists

Recently Published Articles